Latest market price
25.22
+0.09+0.35%
RAPPQT14Rapport Therapeutics, Inc. Common Stock·NASDAQ
25.22+0.35%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 20264Statement of changes in beneficial ownership
Oct 30, 2026424B5Prospectus
Oct 30, 20268-KCurrent report
Oct 30, 2026424B5Prospectus
Oct 29, 2026305B2305B2
Oct 28, 2026FWPFree writing prospectus
Oct 28, 2026FWPFree writing prospectus
Oct 28, 2026FWPFree writing prospectus
Oct 28, 2026FWPFree writing prospectus
Oct 27, 2026424B5Prospectus
Oct 27, 2026424B5Prospectus
Oct 23, 20264Statement of changes in beneficial ownership
Oct 23, 20264Statement of changes in beneficial ownership
Oct 22, 20264Statement of changes in beneficial ownership
Oct 22, 20264Statement of changes in beneficial ownership
Oct 22, 20264Statement of changes in beneficial ownership
Oct 22, 20264Statement of changes in beneficial ownership
Oct 21, 20264Statement of changes in beneficial ownership
Oct 20, 20268-KCurrent report
Oct 08, 20264Statement of changes in beneficial ownership
Oct 01, 20264Statement of changes in beneficial ownership
Sep 24, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Aug 26, 20264Statement of changes in beneficial ownership
Aug 26, 20264Statement of changes in beneficial ownership